BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6504695)

  • 1. [Thrombocytopenia due to antibodies induced by ticlopidine].
    Claas FH; de Fraiture WH; Meyboom RH
    Nouv Rev Fr Hematol (1978); 1984; 26(5):323-4. PubMed ID: 6504695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet sequestration during hypothermia in dogs treated with sulphinpyrazone and ticlopidine--reversibility accelerated after intra-abdominal rewarming.
    Pina-Cabral JM; Ribeiro-da-Silva A; Almeida-Dias A
    Thromb Haemost; 1985 Dec; 54(4):838-41. PubMed ID: 4089817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-induced thrombocytopenia: the role of platelet activation and therapeutic implications.
    Haas S; Walenga JM; Jeske WP; Fareed J
    Semin Thromb Hemost; 1999; 25 Suppl 1():67-75. PubMed ID: 10357155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative detection and management of immune heparin-induced thrombocytopenia in patients undergoing heart surgery with iloprost.
    Palatianos GM; Foroulis CN; Vassili MI; Matsouka P; Astras GM; Kantidakis GH; Iliopoulou E; Melissari EN
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):548-54. PubMed ID: 14762367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of thrombocytopenic episodes caused by the Arthus reaction, the sub-lethal Forssman reaction and ADP.
    Butler KD; White AM
    Artery; 1980; 8(5):457-69. PubMed ID: 6452106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in vitro effect of ticlopidine on fibrinogen and factor VIII binding to human platelets.
    Lee H; Paton RC; Ruan C; Caen JP
    Thromb Haemost; 1981 Oct; 46(3):590-2. PubMed ID: 6797089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of anti-mouse antibodies in thrombocytopenic patients with autoimmune disorders.
    Clofent-Sanchez G; Laroche-Trainean J; Lucas S; Rispal P; Pellegrin JL; Nurden P; Nurden A
    Hum Antibodies; 1997; 8(2):50-9. PubMed ID: 9289388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reticulated platelets in the evaluation of thrombopoietic disorders.
    Rinder HM; Munz UJ; Ault KA; Bonan JL; Smith BR
    Arch Pathol Lab Med; 1993 Jun; 117(6):606-10. PubMed ID: 8503732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ticlopidine on blood fibrinogen and blood viscosity in peripheral atherosclerotic disease.
    Randi ML; Fabris F; Crociani ME; Battocchio F; Girolami A
    Arzneimittelforschung; 1985; 35(12):1847-9. PubMed ID: 4096744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reticulated platelet counts correlate with treatment response in patients with idiopathic thrombocytopenic purpura and help identify the complex causes of thrombocytopenia in patients after allogeneic hematopoietic stem cell transplantation.
    Thomas-Kaskel AK; Mattern D; Köhler G; Finke J; Behringer D
    Cytometry B Clin Cytom; 2007 Jul; 72(4):241-8. PubMed ID: 17266149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale for the use of drugs inhibiting platelet function in claudicating patients with atherosclerotic leg arteries.
    Verstraete M
    Agents Actions Suppl; 1984; 15():173-87. PubMed ID: 6091423
    [No Abstract]   [Full Text] [Related]  

  • 12. Ex vivo effects of ticlopidine on human platelets: inhibition of fibrinogen binding by a mechanism independent of thromboxane formation.
    Iovine C; d'Avenia V; Turco S; Mattioli PL; di Minno G
    Agents Actions Suppl; 1984; 15():105-7. PubMed ID: 6592941
    [No Abstract]   [Full Text] [Related]  

  • 13. The mechanism behind the effect of ALG on platelets in vivo.
    Henricsson A; Husberg B; Bergentz SE
    Clin Exp Immunol; 1977 Sep; 29(3):515-22. PubMed ID: 589869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The timing of a positive test result for heparin-induced thrombocytopenia relative to the platelet count and anticoagulant therapy in 43 consecutive cases.
    Refaai MA; Van Cott EM; Laposata M
    Am J Clin Pathol; 2003 Apr; 119(4):497-504. PubMed ID: 12710122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-existence of heparin-induced thrombocytopenia and thrombotic thrombocytopenic purpura in a postoperative cardiac surgery patient.
    Benke S; Moltzan C
    Am J Hematol; 2005 Dec; 80(4):288-91. PubMed ID: 16315265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic side effects of the platelet-inhibitory drug ticlopidine.
    Berglund U; Wallentin L
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():281-3. PubMed ID: 3159214
    [No Abstract]   [Full Text] [Related]  

  • 17. Idiopathic autoimmune thrombocytopenia: evidence for redistribution of platelet antibodies into the circulation after immunoadsorption treatment.
    Leitner GC; Stiegler G; Horvath M; Hoecker P; Sagaster P; Panzer S
    Am J Hematol; 2003 May; 73(1):44-7. PubMed ID: 12701120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible usefulness of ticlopidine in combined treatment of thrombotic thrombocytopenic purpura. Report of one case.
    De Pasquale A; Venturoni L; Paterlini P; Cretara G; Di Francesco A; Quaglino D
    Haematologica; 1986; 71(1):53-5. PubMed ID: 3084358
    [No Abstract]   [Full Text] [Related]  

  • 19. Pseudothrombocytopenia. In vitro studies on the underlying mechanism.
    Manthorpe R; Kofod B; Wiik A; Saxtrup O; Svehag SE
    Scand J Haematol; 1981 May; 26(5):385-92. PubMed ID: 7336152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Definition and mechanism of drug-induced thrombocytopenia].
    Nomura S
    Rinsho Byori; 2005 Jul; 53(7):617-21. PubMed ID: 16104530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.